Category: 5. Biology

Continue Reading

  • Survival benefit associated with first-line androgen receptor pathway inhibitors for de novo metastatic castration-sensitive prostate cancer

    Survival benefit associated with first-line androgen receptor pathway inhibitors for de novo metastatic castration-sensitive prostate cancer

  • Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12–49.

    PubMed 

    Google Scholar 

  • Piombino C, Oltrecolli M, Tonni E, Pirola M, Matranga R, Baldessari C, et al. De novo…

  • Continue Reading